Meng Welliver

Meng Welliver, MD

Physician

Make an Appointment

Overall Patient Satisfaction Rating

stars
4.7 out of 5
106
Reviews
5
Comments

Gender

Female

Biography


I’m a radiation oncologist with a specialized focus on patients with thoracic cancers, soft tissue sarcomas and blood cancers (including lymphoma, leukemia and myeloma). I serve as Assistant Professor of the Radiation Oncology Department at the OSUCCC – James. Radiation oncologists here have the privilege of subspecializing in different types of cancers, resulting in excellent treatment outcomes.

My clinical approach emphasizes the use of combined modality therapies to treat cancer. By tailoring combined radiation-drug treatment plans to fit the individual cancer patient, we maximize therapeutic efficacy and reduce toxic exposure. I am also actively investigating how best to use novel imaging and radiotherapy techniques to improve radiation treatments.

I enjoy working with world-class colleagues in surgery and oncology at the OSUCCC – James. I’m actively involved in preclinical research and clinical trial design. These trials allow us to determine which drug-radiation combinations are most effective in overcoming treatment resistance and improving patient survival rates.

I’ve been invited to speak at national and international conferences and universities. I also have several published articles in medical journals including Cancer Research, Journal of Clinical Investigation and Molecular Cell.

Education and Background

Education

Pennsylvania State University College of Medicine

Hershey, PA

Residencies

University of Pennsylvania Medical Center

Philadelphia, PA

Board Certifications

American Board of Radiology (Subspecialty: Radiation Oncology)

Academic Department

Department of Radiation Oncology


Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. Welliver has reported no relationships with companies or entities.

Reviews

Patient Satisfaction Review

The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

Overall Ratings (out of 106 reviews)
stars
4.7 out of 5
Kept you informed about your condition and treatment

4.7/ 5

Amount of time spent with you

4.7/ 5

Concern for your questions and issues

4.4/ 5

Skill and knowledge

4.7/ 5

Overall quality of care

4.8/ 5

Patient Comments (5 total comments)

stars
Reviewed: 4/22/2019

Dr. Welliver et al, very kind. Very professional, very patient w/questions and thorough in answering them. Like Allstate, I felt I was in good hands.

stars
Reviewed: 4/14/2019

The doctor treated me and my family with respect and understanding and made sure that we understood my condition and the care planned.

stars
Reviewed: 3/20/2019

Outstanding.

stars
Reviewed: 3/12/2019

We love Dr. Welliver. (Dr. O.!)

stars
Reviewed: 2/25/2019

Excellent.

Publications

Response to the Letter to Editor re: Methodological Issues.

Mo X, Xu-Welliver M

J Thorac Oncol 13

1/1/2018

The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer.

Miller ED, Fisher JL, Haglund KE, Grecula JC, Xu-Welliver M, Bertino EM, He K, Shields PG, Carbone DP, Williams TM, Otterson GA, Bazan JG

J Thorac Oncol 13

1/1/2018

Clinical Trials | Lead

NRG-DT001

OSU-13219

Back to Find a Doctor Search

Make an Appointment

800-293-5066

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Please enter a keyword (i.e. Name, Location) or choose a Cancer Type

OR